A hemoglobin-derived peptide promoted deep sleep through the CB1 cannabinoid receptor in mice
A peptide derived from hemoglobin, (m)VD-hemopressin(alpha), promoted NREM sleep in mice through CB1 cannabinoid receptor activation, adding to evidence that the endocannabinoid system regulates sleep.
Quick Facts
What This Study Found
The hemoglobin-derived peptide (m)VD-HPalpha promoted non-rapid eye movement (NREM) sleep when administered to mice. This sleep-promoting effect was mediated through CB1 cannabinoid receptors, providing new evidence for endocannabinoid system involvement in sleep regulation.
Key Numbers
(m)VD-HPalpha, an 11-residue peptide, promoted NREM sleep in mice. Effect was CB1 receptor-dependent.
How They Did This
Animal study examining sleep architecture in mice following administration of (m)VD-hemopressin(alpha). Sleep stages monitored. CB1 receptor involvement confirmed using pharmacological tools.
Why This Research Matters
Sleep disruption is one of the most common reasons people use cannabis. Understanding how the endocannabinoid system naturally regulates sleep could lead to targeted sleep therapeutics without the side effects of whole-plant cannabis.
The Bigger Picture
Endogenous cannabinoid-related peptides like hemopressin are revealing new layers of the endocannabinoid system. If specific peptides promote sleep through CB1 receptors, they could inspire sleep medications that leverage the body's own signaling.
What This Study Doesn't Tell Us
Mouse study with uncertain human translation. Direct peptide administration to the brain is not a clinically feasible route. Sleep architecture differs between mice and humans. Unknown whether this peptide plays a role in natural human sleep.
Questions This Raises
- ?Could hemopressin-related peptides be developed into sleep medications?
- ?Does endogenous hemopressin contribute to the sleep-promoting effects reported by cannabis users?
Trust & Context
- Key Stat:
- Hemoglobin-derived peptide promoted NREM sleep via CB1 receptors in mice
- Evidence Grade:
- Well-designed mechanistic animal study. Very early-stage finding with no immediate clinical application.
- Study Age:
- Published 2023.
- Original Title:
- An α-hemoglobin-derived peptide (m)VD-hemopressin (α) promotes NREM sleep via the CB1 cannabinoid receptor.
- Published In:
- Frontiers in pharmacology, 14, 1213215 (2023)
- Authors:
- Xie, Jun-Fan, Wang, Lin-Xin, Ren, Wen-Ting, Wang, Can, Gao, Jin-Xian, Chen, Hai-Lin, Zhao, Xue-Qi, Ren, Yan-Li, Xie, Yu-Ping, Shao, Yu-Feng, Hou, Yi-Ping
- Database ID:
- RTHC-05038
Evidence Hierarchy
Frequently Asked Questions
Does the cannabinoid system control sleep?
Growing evidence supports this. This study found that a peptide that interacts with CB1 cannabinoid receptors promoted deep (NREM) sleep in mice. The endocannabinoid system appears to be one of several systems that regulate when and how well we sleep.
Is this why cannabis helps people sleep?
The finding that CB1 receptor activation promotes sleep in mice is consistent with reports from cannabis users. However, many pathways are involved, and this specific peptide is not the same as THC. Whether this particular mechanism explains cannabis sleep effects in humans is unknown.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-05038APA
Xie, Jun-Fan; Wang, Lin-Xin; Ren, Wen-Ting; Wang, Can; Gao, Jin-Xian; Chen, Hai-Lin; Zhao, Xue-Qi; Ren, Yan-Li; Xie, Yu-Ping; Shao, Yu-Feng; Hou, Yi-Ping. (2023). An α-hemoglobin-derived peptide (m)VD-hemopressin (α) promotes NREM sleep via the CB1 cannabinoid receptor.. Frontiers in pharmacology, 14, 1213215. https://doi.org/10.3389/fphar.2023.1213215
MLA
Xie, Jun-Fan, et al. "An α-hemoglobin-derived peptide (m)VD-hemopressin (α) promotes NREM sleep via the CB1 cannabinoid receptor.." Frontiers in pharmacology, 2023. https://doi.org/10.3389/fphar.2023.1213215
RethinkTHC
RethinkTHC Research Database. "An α-hemoglobin-derived peptide (m)VD-hemopressin (α) promot..." RTHC-05038. Retrieved from https://rethinkthc.com/research/xie-2023-an-hemoglobinderived-peptide-mvdhemopressin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.